Filters

See more specimen types...

Other countries

Results: 1 to 20 of 45

Tests names and labsConditionsGenes and analytesMethods

CentoICU platinum

Centogene AG - the Rare Disease Company
Germany
769514
  • C Sequence analysis of the entire coding region

CentoICU platinum plus

Centogene AG - the Rare Disease Company
Germany
769514
  • C Sequence analysis of the entire coding region

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
6021038
  • C Sequence analysis of the entire coding region

Congenital Muscular Dystrophy Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
4024
  • C Sequence analysis of the entire coding region

Congenital Muscular Dystrophy Deletion/Duplication Analysis

Genetic Services Laboratory University of Chicago
United States
3923
  • D Deletion/duplication analysis

Muscular dystrophy type 1A

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cerebral Cortical Malformation Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
5553
  • C Sequence analysis of the entire coding region

LAMA2. NextGeneDx.Complete sequencing by NGS

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15411578
  • C Sequence analysis of the entire coding region

LAMA2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Merosin-Deficient Congenital Muscular Dystrophy (MDC1A) via the LAMA2 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Congenital Muscular Dystrophy NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
3025
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Merosin-Deficient Congenital Muscular Dystrophy (MDC1A) via the LAMA2 Gene (Mexican Exon 55 Mutation)

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Comprehensive Epilepsy NGS Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
3055447
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

DYSTROPHIES, CONGENITAL MUSCULAR

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
2112
  • C Sequence analysis of the entire coding region

Muscular dystrophy type 1A, Congenital: LAMA2 gene deletions-duplications analysis (MLPA)

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
11
  • D Deletion/duplication analysis

Neuromuscular Disorders Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
9988
  • C Sequence analysis of the entire coding region

Merosin deficiency

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Congenital muscular dystrophy due to laminin alpha2 deficiency

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Single gene testing LAMA2

CeGaT GmbH
Germany
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 45

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.